Standardization of intralesional meglumine antimoniate treatment for cutaneous leishmaniasis
Rev. Soc. Bras. Med. Trop
; 49(6): 774-776, Dec. 2016. graf
Article
em En
| LILACS
| ID: biblio-1041383
Biblioteca responsável:
BR1.1
ABSTRACT
Abstract INTRODUCTION:
Intralesional treatment for cutaneous leishmaniasis has been applied for over 30 years at the Oswaldo Cruz Foundation, Rio de Janeiro, with good therapeutic results and without relevant systemic toxicity. METHODS Meglumine antimoniate was injected subcutaneously, using a long medium-caliber needle (for example, 30mm × 0.8mm); patients received 1-3 injections, with 15-day intervals. RESULTS The technique is described in detail sufficient to enable replication.CONCLUSIONS:
The treatment of cutaneous leishmaniasis with intralesional meglumine antimoniate is a simple, effective, and safe technique, which may be used in basic healthcare settings.Palavras-chave
Texto completo:
1
Índice:
LILACS
Assunto principal:
Compostos Organometálicos
/
Leishmaniose Cutânea
/
Meglumina
/
Antiprotozoários
Limite:
Humans
Idioma:
En
Revista:
Rev. Soc. Bras. Med. Trop
Assunto da revista:
MEDICINA TROPICAL
Ano de publicação:
2016
Tipo de documento:
Article